Working... Menu

Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00079716
Recruitment Status : Completed
First Posted : March 16, 2004
Last Update Posted : December 18, 2014
Genentech, Inc.
Information provided by:
Seattle Genetics, Inc.